Expert Perspectives on Biosimilar Agents
  • Program Overview
    Expert Perspectives on Biosimilar Agents
    This in-depth educational program, which features a video module, downloadable slideset with slidenotes, and a series of ClinicalThought commentaries, illuminates expert perspectives on biosimilars with a specific emphasis on their application in the oncology, rheumatology, and gastroenterology specialites.
  • Featured content
    Multiple biosimilars are now approved for the treatment of active cancers. Here’s what oncologists need to know.
    Date Posted: 1/18/2018
  • Featured content
    In these downloadable slides, a multidisciplinary panel of expert faculty discuss the use of biosimilars across oncology, rheumatology, dermatology, and gastroenterology specialties.
    Date Posted: 11/16/2017
  • Featured content
    In this video module, a multidisciplinary panel of expert faculty discuss the use of biosimilars across oncology, rheumatology, dermatology, and gastroenterology specialties.
  • 1
  • 2
  • 3
  • 4

Latest Content

3 of 3 Shown
  • My Take: Integrating Biosimilars Into an Oncology Practice

    Hope S. Rugo MD - 1/18/2018
    Multiple biosimilars are now approved for the treatment of active cancers. Here’s what oncologists need to know.
  • Expert Perspectives on Biosimilar Agents

    In these downloadable slides, a multidisciplinary panel of expert faculty discuss the use of biosimilars across oncology, rheumatology, dermatology, and gastroenterology specialties.
    Date Posted: 11/16/2017
  • Video Module cme-icon

    Expert Perspectives on Biosimilar Agents

    In this video module, a multidisciplinary panel of expert faculty discuss the use of biosimilars across oncology, rheumatology, dermatology, and gastroenterology specialties.
    Faculty: Andrew M. Evens DO, MSc, FACP, Jonathan Kay MD, Alan C. Moss MD
    Released: 11/16/2017
3 of 3 Shown
Show 0 More
Loading...